Technical Analysis for EPRX - Eupraxia Pharmaceuticals Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 3.700 | 5.71% | 0.200 |
Earnings due: Aug 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Crossed Above 50 DMA | Bullish | 0.00% | |
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| 50 DMA Resistance | Bearish | 5.71% | |
| Fell Below 20 DMA | Bearish | 5.71% | |
| 180 Bearish Setup | Bearish Swing Setup | 5.71% | |
| Crossed Above 20 DMA | Bullish | 2.78% | |
| MACD Bullish Signal Line Cross | Bullish | 2.78% | |
| Lower Bollinger Band Touch | Weakness | 2.78% | |
| 20 DMA Resistance | Bearish | 6.94% |
| Alert | Time |
|---|---|
| Possible Inside Day | about 8 hours ago |
| Possible NR7 | about 8 hours ago |
| Up 2% | about 11 hours ago |
| Rose Above 20 DMA | about 12 hours ago |
| Rose Above 10 DMA | about 12 hours ago |
Get a Trading Sidekick!
- Earnings date: 2024-08-09
Eupraxia Pharmaceuticals Inc Description
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate, EP-104IAR, that is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treatment of canine and equine osteoarthritis. Its products in development also include EP-201, a product candidate for prophylaxis of post-surgical infections; and EP-105, an extended-release product candidate for the local delivery of anesthetics to treat post-surgical pain. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was founded in 2012 and is headquartered in Victoria, Canada.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Pain Life Sciences Arthritis Osteoarthritis Skeletal Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.46 |
| 52 Week Low | 3.25 |
| Average Volume | 14,771 |
| 200-Day Moving Average | 4.926 |
| 50-Day Moving Average | 3.647 |
| 20-Day Moving Average | 3.534 |
| 10-Day Moving Average | 3.529 |
| Average True Range | 0.165 |
| RSI (14) | 56.33 |
| ADX | 27.78 |
| +DI | 14.324 |
| -DI | 23.370 |
| Chandelier Exit (Long, 3 ATRs) | 3.246 |
| Chandelier Exit (Short, 3 ATRs) | 3.744 |
| Upper Bollinger Bands | 3.738 |
| Lower Bollinger Band | 3.329 |
| Percent B (%b) | 0.91 |
| BandWidth | 11.558 |
| MACD Line | -0.024 |
| MACD Signal Line | -0.041 |
| MACD Histogram | 0.0177 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.940 | ||||
| Resistance 3 (R3) | 3.913 | 3.807 | 3.900 | ||
| Resistance 2 (R2) | 3.807 | 3.746 | 3.820 | 3.887 | |
| Resistance 1 (R1) | 3.753 | 3.708 | 3.780 | 3.780 | 3.873 |
| Pivot Point | 3.647 | 3.647 | 3.660 | 3.660 | 3.647 |
| Support 1 (S1) | 3.593 | 3.586 | 3.620 | 3.620 | 3.527 |
| Support 2 (S2) | 3.487 | 3.548 | 3.500 | 3.513 | |
| Support 3 (S3) | 3.433 | 3.487 | 3.500 | ||
| Support 4 (S4) | 3.460 |
